Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT02188563
Official study title

A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers

Study summary

Smoking is the greatest risk factor for upper aerodigestive cancers (thoracic or head and neck) and negatively impacts survival and other outcomes, but many patients have difficulty quitting after their diagnosis. Smoking cessation interventions for cancer patients thus far have had limited success. This is a pilot randomized controlled trial designed to determine if a new comprehensive, evidence-based smoking cessation intervention can improve quit rates for cancer patients who smoke.

Ask AI to explain this study
Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedComprehensive smoking cessation intervention and Enhanced usual care

The study team can explain what participation involves.

Who it may be forTobacco Use Disorder · Head and Neck Neoplasms

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jan 17, 2019 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Study sponsor

01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Not applicable
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Interventions being studied
Other: Comprehensive smoking cessation intervention; Behavioral: Enhanced usual care
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • New diagnosis of head and neck or thoracic (including lung) cancer
  • Undergoing radiation at Johns Hopkins Radiation Oncology for 5 or more weeks
  • English-speaking and able to provide informed consent
  • Smoked any cigarettes in previous 14 days
Reasons someone may not be able to joinExclusion criteria
  • Palliative radiation
  • Undergoing stereotactic radiosurgery
  • Pregnant or breastfeeding

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Johns Hopkins MedicineBaltimore, Maryland

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 17, 2019. Always confirm current availability with the study team.

View original record ↗